These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23937443)

  • 1. Pharmacological treatment for keloids.
    Huang C; Ogawa R
    Expert Opin Pharmacother; 2013 Oct; 14(15):2087-100. PubMed ID: 23937443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
    Dienus K; Bayat A; Gilmore BF; Seifert O
    Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered angiogenic balance in keloids: a key to therapeutic intervention.
    Mogili NS; Krishnaswamy VR; Jayaraman M; Rajaram R; Venkatraman A; Korrapati PS
    Transl Res; 2012 Mar; 159(3):182-9. PubMed ID: 22340768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Keloids. A fibroproliferative disorder of unknown etiology].
    Bock O; Mrowietz U
    Hautarzt; 2002 Aug; 53(8):515-23. PubMed ID: 12221465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment.
    Andrews JP; Marttala J; Macarak E; Rosenbloom J; Uitto J
    Matrix Biol; 2016 Apr; 51():37-46. PubMed ID: 26844756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keloids show regional distribution of proliferative and degenerate connective tissue elements.
    Bux S; Madaree A
    Cells Tissues Organs; 2010; 191(3):213-34. PubMed ID: 19641294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondroitinase injection improves keloid pathology by reorganizing the extracellular matrix with regenerated elastic fibers.
    Ishiko T; Naitoh M; Kubota H; Yamawaki S; Ikeda M; Yoshikawa K; Fujita H; Yamaguchi H; Kurahashi Y; Suzuki S
    J Dermatol; 2013 May; 40(5):380-3. PubMed ID: 23451938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of unique gene expression patterns within different lesional sites of keloids.
    Seifert O; Bayat A; Geffers R; Dienus K; Buer J; Löfgren S; Matussek A
    Wound Repair Regen; 2008; 16(2):254-65. PubMed ID: 18282266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated prolidase activity in keloids: correlation with type I collagen turnover.
    Duong HS; Zhang QZ; Le AD; Kelly AP; Kamdar R; Messadi DV
    Br J Dermatol; 2006 May; 154(5):820-8. PubMed ID: 16634881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of keloid and hypertrophic scar formation.
    Tuan TL; Nichter LS
    Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The keloid phenomenon: progress toward a solution.
    Louw L
    Clin Anat; 2007 Jan; 20(1):3-14. PubMed ID: 16944532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keloids: a new challenge for nutrition.
    Ferreira AC; Hochman B; Furtado F; Bonatti S; Ferreira LM
    Nutr Rev; 2010 Jul; 68(7):409-17. PubMed ID: 20591108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keloid and hypertrophic scarring may result from a mechanoreceptor or mechanosensitive nociceptor disorder.
    Ogawa R
    Med Hypotheses; 2008 Oct; 71(4):493-500. PubMed ID: 18614294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role?
    Mukhopadhyay A; Do DV; Ong CT; Khoo YT; Masilamani J; Chan SY; Vincent AS; Wong PK; Lim CP; Cao X; Lim IJ; Phan TT
    Br J Dermatol; 2011 Feb; 164(2):372-86. PubMed ID: 20846303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological therapy of keloids in an athymic mouse model].
    Blazek J; Ottomann C; Muehlberger T
    Handchir Mikrochir Plast Chir; 2008 Apr; 40(2):81-7. PubMed ID: 18437665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of keloid formation in humans and laboratory animals.
    Khorshid FA
    Med Sci Monit; 2005 Jul; 11(7):BR212-9. PubMed ID: 15990682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated vascular endothelial growth factor in keloids: relevance to tissue fibrosis.
    Le AD; Zhang Q; Wu Y; Messadi DV; Akhondzadeh A; Nguyen AL; Aghaloo TL; Kelly AP; Bertolami CN
    Cells Tissues Organs; 2004; 176(1-3):87-94. PubMed ID: 14745238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Madecassoside suppresses migration of fibroblasts from keloids: involvement of p38 kinase and PI3K signaling pathways.
    Song J; Xu H; Lu Q; Xu Z; Bian D; Xia Y; Wei Z; Gong Z; Dai Y
    Burns; 2012 Aug; 38(5):677-84. PubMed ID: 22360962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 signaling pathway in keloids: a target for pharmacologic intervention?
    Uitto J
    J Invest Dermatol; 2007 Jan; 127(1):6-8. PubMed ID: 17170717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DHMEQ, a novel NF-kappaB inhibitor, suppresses growth and type I collagen accumulation in keloid fibroblasts.
    Makino S; Mitsutake N; Nakashima M; Saenko VA; Ohtsuru A; Umezawa K; Tanaka K; Hirano A; Yamashita S
    J Dermatol Sci; 2008 Sep; 51(3):171-80. PubMed ID: 18406579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.